ATYR
aTYR PHARMA INCTrades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-27 | SCHIMMEL PAUL |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Represents weighted average price for the shares. The shares were purchased at prices ranging from $0.4907 to $0.50 per share. The Reporting Person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000. |
Common Stock
(I)
|
100,000 |
| 2026-05-11 | SCHIMMEL PAUL |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 11, 2027 or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. |
Stock Option (right to buy)
|
50,000 |
| 2026-05-11 | Gross Jane A |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 11, 2027 or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. |
Stock Option (right to buy)
|
50,000 |
| 2026-05-11 | BENEVICH ERIC |
Chief Commercial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 11, 2027 or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. |
Stock Option (right to buy)
|
50,000 |
| 2026-05-11 | Zaknoen Sara |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 11, 2027 or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. |
Stock Option (right to buy)
|
50,000 |
| 2026-05-11 | Lucas Svetlana |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 11, 2027 or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. |
Stock Option (right to buy)
|
50,000 |
| 2026-05-11 | COUGHLIN TIMOTHY |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 11, 2027 or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. |
Stock Option (right to buy)
|
50,000 |
| 2026-02-04 | DENYES NANCY |
General Counsel |
Sell↓
Filing footnotes — Common Stock (Direct)
Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 3, 2022. |
Common Stock
|
1,118 |
| 2026-02-04 | Shukla Sanjay |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 3, 2022. |
Common Stock
|
3,745 |
| 2026-02-04 | Broadfoot Jill Marie |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 3, 2022. |
Common Stock
|
1,558 |
| 2026-02-03 | DENYES NANCY |
General Counsel |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Restricted stock units convert into common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. |
Restricted Stock Unit
|
2,687 |
| 2026-02-03 | Shukla Sanjay |
Director, President and CEO |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Restricted stock units convert into common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. |
Restricted Stock Unit
|
10,375 |
| 2026-02-03 | Broadfoot Jill Marie |
Chief Financial Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Restricted stock units convert into common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. |
Restricted Stock Unit
|
3,750 |
| 2026-02-03 | Broadfoot Jill Marie |
Chief Financial Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022. Restricted stock units convert into common stock on a one-for-one basis. |
Common Stock
|
3,750 |
| 2026-02-03 | DENYES NANCY |
General Counsel |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022. Restricted stock units convert into common stock on a one-for-one basis. |
Common Stock
|
2,687 |
| 2026-02-03 | Shukla Sanjay |
Director, President and CEO |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022. Restricted stock units convert into common stock on a one-for-one basis. |
Common Stock
|
10,375 |
| 2026-01-09 | Shukla Sanjay |
Director, President and CEO |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning February 9, 2026, such that this option will be fully exercisable on January 9, 2029. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. |
Employee Stock Option (right to buy)
|
1,500,000 |
| 2026-01-09 | DENYES NANCY |
General Counsel |
Award↑
Filing footnotes — Employee Stock Options (right to buy) (Direct)
The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning February 9, 2026, such that this option will be fully exercisable on January 9, 2029. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. |
Employee Stock Options (right to buy)
|
412,500 |
| 2026-01-09 | Broadfoot Jill Marie |
Chief Financial Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning February 9, 2026, such that this option will be fully exercisable on January 9, 2029. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. |
Employee Stock Option (right to buy)
|
412,500 |
| 2025-10-09 | SCHIMMEL PAUL |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Represents weighted average price for the shares. The shares were purchased at prices ranging from $0.93 to $0.95 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. |
Common Stock
(I)
|
317,999 |
| 2025-10-08 | SCHIMMEL PAUL |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Represents weighted average price for the shares. The shares were purchased at prices ranging from $0.8536 to $0.95 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. |
Common Stock
(I)
|
682,001 |
| 2025-05-01 | Zaknoen Sara |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 1, 2026 or (ii) the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. |
Stock Option (right to buy)
|
50,000 |
| 2025-05-01 | Gross Jane A |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 1, 2026 or (ii) the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. |
Stock Option (right to buy)
|
50,000 |
| 2025-05-01 | COUGHLIN TIMOTHY |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 1, 2026 or (ii) the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. |
Stock Option (right to buy)
|
50,000 |
| 2025-05-01 | SCHIMMEL PAUL |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 1, 2026 or (ii) the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. |
Stock Option (right to buy)
|
50,000 |
| 2025-05-01 | Lucas Svetlana |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 1, 2026 or (ii) the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. |
Stock Option (right to buy)
|
50,000 |
| 2025-05-01 | BENEVICH ERIC |
Chief Commercial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 1, 2026 or (ii) the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. |
Stock Option (right to buy)
|
50,000 |
| 2025-03-17 | Gross Jane A |
Director |
Buy↑
|
Common Stock
|
3,750 |
| 2025-02-04 | Broadfoot Jill Marie |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 3, 2022. |
Common Stock
|
1,254 |
| 2025-02-04 | DENYES NANCY |
General Counsel |
Sell↓
Filing footnotes — Common Stock (Direct)
Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 3, 2022. |
Common Stock
|
899 |
| 2025-02-03 | DENYES NANCY |
General Counsel |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Restricted stock units convert into common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. |
Restricted Stock Unit
|
2,687 |
| 2025-02-03 | Shukla Sanjay |
Director, President and CEO |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022. Restricted stock units convert into common stock on a one-for-one basis. |
Common Stock
|
10,375 |
| 2025-02-03 | Broadfoot Jill Marie |
Chief Financial Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Restricted stock units convert into common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. |
Restricted Stock Unit
|
3,750 |
| 2025-02-03 | Shukla Sanjay |
Director, President and CEO |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Restricted stock units convert into common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. |
Restricted Stock Unit
|
10,375 |
| 2025-02-03 | DENYES NANCY |
General Counsel |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022. Restricted stock units convert into common stock on a one-for-one basis. Includes 2,500 shares acquired on November 15, 2024 under the Company's 2015 Employee Purchase Plan. |
Common Stock
|
2,687 |
| 2025-02-03 | Broadfoot Jill Marie |
Chief Financial Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022. Restricted stock units convert into common stock on a one-for-one basis. Includes 1,307 shares acquired on November 15, 2024 under the Company's 2015 Employee Purchase Plan. |
Common Stock
|
3,750 |
| 2025-01-08 | Broadfoot Jill Marie |
Chief Financial Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 8, 2025, such that this option will be fully exercisable on January 8, 2029. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. |
Employee Stock Option (right to buy)
|
275,000 |
| 2025-01-08 | Shukla Sanjay |
Director, President and CEO |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 8, 2025, such that this option will be fully exercisable on January 8, 2029. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. |
Employee Stock Option (right to buy)
|
1,000,000 |
| 2025-01-08 | DENYES NANCY |
General Counsel |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 8, 2025, such that this option will be fully exercisable on January 8, 2029. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. |
Employee Stock Option (right to buy)
|
275,000 |
| 2024-12-10 | BENEVICH ERIC |
Chief Commercial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning January 10, 2025, such that this option will be fully exercisable on December 10, 2027, subject to the recipient's continued service on the Issuer's Board of Directors. |
Stock Option (right to buy)
|
100,000 |
| 2024-12-10 | BENEVICH ERIC |
Chief Commercial Officer |
Other↑
|
No Securities Owned
|
0 |
| 2024-07-24 | SCHIMMEL PAUL |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.88 to $1.96 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. These shares are owned by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. |
Common Stock
(I)
|
52,300 |
| 2024-07-23 | SCHIMMEL PAUL |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.775 to $1.86 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. These shares are owned by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. |
Common Stock
(I)
|
6,648 |
| 2024-07-22 | SCHIMMEL PAUL |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.71 to $1.78 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. These shares are owned by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. |
Common Stock
(I)
|
41,052 |
| 2024-06-05 | DENYES NANCY |
General Counsel |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.835 to $1.87 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Includes 2,500 shares acquired on May 15, 2024 under the Company's 2015 Employee Purchase Plan. |
Common Stock
|
5,000 |
| 2024-05-31 | Shukla Sanjay |
Director, President and CEO |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.77 to $1.86 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. |
Common Stock
|
20,000 |
| 2024-05-31 | Broadfoot Jill Marie |
Chief Financial Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Includes 2,139 shares acquired on May 15, 2024 under the Company's 2015 Employee Purchase Plan. |
Common Stock
|
5,000 |
| 2024-05-30 | COUGHLIN TIMOTHY |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.665 to $1.80 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. These shares are owned by the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person and his spouse serve as co-trustees of the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person may be deemed to be the beneficial owner of the securities held by the Coughlin Family Trust u/a DTD 12/07/2006. |
Common Stock
(I)
|
50,000 |
| 2024-05-22 | CLARKE JOHN K |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. |
Stock Option (right to buy)
|
24,000 |
| 2024-05-22 | SCHIMMEL PAUL |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. |
Stock Option (right to buy)
|
24,000 |